FR2518403B1 - Procede de preparation de formes pharmaceutiques presentant une resorption par voie digestive amelioree, et les formes pharmaceutiques ainsi obtenues - Google Patents

Procede de preparation de formes pharmaceutiques presentant une resorption par voie digestive amelioree, et les formes pharmaceutiques ainsi obtenues

Info

Publication number
FR2518403B1
FR2518403B1 FR8123907A FR8123907A FR2518403B1 FR 2518403 B1 FR2518403 B1 FR 2518403B1 FR 8123907 A FR8123907 A FR 8123907A FR 8123907 A FR8123907 A FR 8123907A FR 2518403 B1 FR2518403 B1 FR 2518403B1
Authority
FR
France
Prior art keywords
pharmaceutical forms
preparation
improved digestive
resorption
digestive resorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8123907A
Other languages
English (en)
Other versions
FR2518403A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR8123907A priority Critical patent/FR2518403B1/fr
Priority to EP19830900046 priority patent/EP0097663A1/fr
Priority to PCT/FR1982/000219 priority patent/WO1983002230A1/fr
Publication of FR2518403A1 publication Critical patent/FR2518403A1/fr
Application granted granted Critical
Publication of FR2518403B1 publication Critical patent/FR2518403B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8123907A 1981-12-22 1981-12-22 Procede de preparation de formes pharmaceutiques presentant une resorption par voie digestive amelioree, et les formes pharmaceutiques ainsi obtenues Expired FR2518403B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR8123907A FR2518403B1 (fr) 1981-12-22 1981-12-22 Procede de preparation de formes pharmaceutiques presentant une resorption par voie digestive amelioree, et les formes pharmaceutiques ainsi obtenues
EP19830900046 EP0097663A1 (fr) 1981-12-22 1982-12-22 Preparation de formes pharmaceutiques seches a resorption amelioree ainsi que ces formes
PCT/FR1982/000219 WO1983002230A1 (fr) 1981-12-22 1982-12-22 Preparation de formes pharmaceutiques seches a resorption amelioree ainsi que ces formes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8123907A FR2518403B1 (fr) 1981-12-22 1981-12-22 Procede de preparation de formes pharmaceutiques presentant une resorption par voie digestive amelioree, et les formes pharmaceutiques ainsi obtenues

Publications (2)

Publication Number Publication Date
FR2518403A1 FR2518403A1 (fr) 1983-06-24
FR2518403B1 true FR2518403B1 (fr) 1987-01-02

Family

ID=9265250

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8123907A Expired FR2518403B1 (fr) 1981-12-22 1981-12-22 Procede de preparation de formes pharmaceutiques presentant une resorption par voie digestive amelioree, et les formes pharmaceutiques ainsi obtenues

Country Status (3)

Country Link
EP (1) EP0097663A1 (fr)
FR (1) FR2518403B1 (fr)
WO (1) WO1983002230A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8600050A (nl) * 1986-01-13 1987-08-03 Sanico Nv Farmaceutisch preparaat met vertraagde afgifte van het werkzame bestanddeel en werkwijze voor de bereiding er van.
US4983605A (en) * 1986-10-23 1991-01-08 Ishihara Sangyo Kaisha Ltd. Pharmaceutical composition
EP0317780B1 (fr) * 1987-11-25 1992-05-20 American Cyanamid Company Système de délivrance retardée (contrôlée) de dihydropyridine antagonistes de calcium substitués
JPH0278699A (ja) * 1988-09-12 1990-03-19 Green Cross Corp:The ベンゾイルウレア系化合物・アルブミン複合体
US5342612A (en) * 1991-12-20 1994-08-30 American Cyanamid Company Compositions for the treatment of mammalian diseases
CN102327215A (zh) * 2011-09-25 2012-01-25 西北农林科技大学 一种麦迪霉素纳米乳药抗菌药物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2226162A1 (en) * 1973-04-17 1974-11-15 Chugai Pharmaceutical Co Ltd Oligosaccharide sulphuric acid ester - for treatment of arteriosclerosis

Also Published As

Publication number Publication date
WO1983002230A1 (fr) 1983-07-07
EP0097663A1 (fr) 1984-01-11
FR2518403A1 (fr) 1983-06-24

Similar Documents

Publication Publication Date Title
FR2722984B1 (fr) Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
FR2507183B1 (fr) Procede de preparation d'acides 6,8-difluoro-1,4-dihydro-4-oxo-quinoleine-3-carboxyliques
MA22481A1 (fr) Procede de preparation d'acides imidazolyl - alcenoiques .
MA23528A1 (fr) Procede de preparation de produits pharmaceutiques
BE879487A (fr) Comprimes pharmaceutique pour une application par voie orale et son procede de preparation
MC1913A1 (fr) Procede de preparation de peptides et peptides ainsi obtenus
MA23518A1 (fr) Procede de preparation de produits pharmaceutiques
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
FR2518403B1 (fr) Procede de preparation de formes pharmaceutiques presentant une resorption par voie digestive amelioree, et les formes pharmaceutiques ainsi obtenues
MA21854A1 (fr) Procede de preparation de phosphonomethyl thioethoxypurines .
FR2599369B1 (fr) Procede de preparation de disilylmethanes
FR2515653B1 (fr) Procede de preparation d'esters d'acides hydroxyimino apovincaminiques, esters ainsi obtenus, et compositions pharmaceutiques preparees avec ces esters
MA21657A1 (fr) Procede de preparation de precurseurs des 3-acyl-2- oxindole-1- carboxamides auto-inflammatoires .
MA21130A1 (fr) Procede de preparation de nouveaux aminopropionamides .
MA22880A1 (fr) Procede de preparation de produits pharmaceutiques .
FR2618779B1 (fr) Nouveau procede de preparation des 1,2,4-triazol-3-ones
FR2643902B1 (fr) Procede de preparation de n-allylmetatrifluoromethylaniline
BE883403A (fr) Procede de preparation de 5-mercapto-1,2,3-triazoles et produits ainsi obtenus
FR2688001B1 (fr) Procede de preparation de p-aminophenols.
FR2610924B1 (fr) Procede de preparation d'hydroxybiphenyles
FR2669330B1 (fr) Procede de preparation de l'acide betha-mercaptopropionique.
FR2519638B1 (fr) Derives d'aminopropylaminobleomycine, leurs applications therapeutiques et procede pour leur preparation
FR2604703B1 (fr) Procede de preparation de polyfluoroenolates
FR2569194B3 (fr) Procede de preparation d'une aminolactone
FR2556338B1 (fr) Procede de preparation d'explosifs par voie humide

Legal Events

Date Code Title Description
ST Notification of lapse